Subthalamic Nucleus Stimulation With Directional Leads on Patients With Parkinson Disease at Fluctuations and Dyskinesia Stage (NSTBOS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT05103072|
Recruitment Status : Recruiting
First Posted : November 2, 2021
Last Update Posted : November 2, 2021
Patients with subthalamic nucleus have to go through a lot of examinations and tests, before and after surgery which is difficult, sometimes painful, for the patient.
The investigators used to chose the best plot of the leads for stimulation by a procedure long and exhausting for the patient and the examinator.
The investigators can chose the plot using a software (Guide Xt), which can delete the exhausting test.
The investigators would like to study the non inferiority of this tool to choose the best plot .
|Condition or disease|
|Parkinson Disease Subthalamic Nucleus Stimulation Directional Electrodes|
|Study Type :||Observational|
|Estimated Enrollment :||13 participants|
|Official Title:||Subthalamic Nucleus Stimulation With Directional Leads on Patients With Parkinson Disease at Fluctuations and Dyskinesia Stage|
|Actual Study Start Date :||September 21, 2021|
|Estimated Primary Completion Date :||December 2022|
|Estimated Study Completion Date :||September 2023|
testing all the plots
the investigator chose the best plot of the leads for stimulation by a procedure long and exhausting for the patient and the examinator (" plot by plot ")
Guide X Software
the investigator can chose the plot using a software (Guide Xt), which can delete the exhausting test
- Increase of MDS UPDRS 3 score [ Time Frame: 3 months ]
The MDS-UPDRS was developed to evaluate various aspects of Parkinson's disease including non-motor and motor experiences of daily living and motor complications.
The MDS-UPDRS has four parts, namely, I: Non-motor Experiences of Daily Living; II: Motor Experiences of DailyLiving; III: Motor Examination; IV: Motor Complications.Twenty questions are completed by the patient/caregiver. Item-specific instructions and an appendix of complementary additional scales are provided.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05103072
|Contact: Melissa TIR, MDfirstname.lastname@example.org|
|CHU Amiens Picardie||Recruiting|
|Amiens, Picardie, France, 80054|
|Contact: Melissa TIR, Dr +33322667987 email@example.com|